RYAN MELLER: Open Payments
NPI 1730660408 · SENECA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 37 payments from 15 companies in 2025. Trend: 2023 $220 · 2024 $1,015 · 2025 $1,060
Food & beverage: $960Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $229 |
| Merck Sharp & Dohme LLC | 2 | $154 |
| E.R. Squibb & Sons, L.L.C. | 9 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Gilead Sciences, Inc. | 2 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Janssen Biotech, Inc. | 1 | $40 |
| Eisai Inc. | 1 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
Products named: Enhertu, KEYTRUDA, Nubeqa, OPDIVO, Trodelvy, SCEMBLIX, OPDUALAG, RYBREVANT.
Industry payments across SC — which companies pay providers there.
